Document Detail

In vitro evaluation of the safe margin, antithrombotic and antiproliferative actions for the treatment of restenosis: Nitric oxide donor and polymers.
MedLine Citation:
PMID:  21374644     Owner:  NLM     Status:  Publisher    
Drug-eluting stents (DES) were developed to combat the problem of in-stent restenosis, and evaluating the biological activity from DES systems is critical for its safety and efficacy. To test the cytotoxicity of nitric oxide (NO) donor-containing polymers for their potential use in DES applications, S-nitrosoglutathione (GSNO) or in combination with poly(vinyl alcohol) (PVA) and poly(vinyl pyrrolidone) (PVP) in an aqueous polymeric solution (PVA/PVP/GSNO) was investigated using Balb/c 3T3 and Rabbit arterial smooth muscle (RASM) cells. The sensitivity of 3T3 cells to the cytotoxicity effects induced by GSNO was higher than that of RASM cells, while RASM cells were more susceptible to alterations in membrane permeability. Cell growth assays showed that GSNO and PVA/PVP/GSNO induced antiproliferative effects in RASM cells. Moreover, the presence of polymers can reduce the cytotoxicity and enhance the antiproliferative effects of GSNO. Dose-dependent inhibition of platelet aggregation was similar for both PVA/PVP/GSNO (EC50 of 3.4 ± 2.3 µM) and GSNO (EC50 of 2.8 ± 1.1 µM) solutions. Platelet adhesion assays showed that the inhibition caused by GSNO (EC50 of 5.0 mM) was dependent on the presence of plasma. These results demonstrate that the methodology adopted here is suitable to establish safety margins and evaluate the antithrombotic potential and antiproliferative effects of NO-eluting biomaterials and polymeric solutions for the new cardiovascular devices, and also to emphasize the importance of using more specific cell lines in these evaluations. Copyright © 2011 John Wiley & Sons, Ltd.
Cláudia de Lourdes Sorragi; Silvia Mika Shishido; Maria Edwiges Lemos; Sissi Marcondes; Edson Antunes; Marta H Krieger
Related Documents :
21507644 - Cytotoxic and ppars transcriptional activities of sterols from the vietnamese soft cora...
11032024 - Characterization of a novel quiescence responsive element downregulated by v-src in the...
20885964 - Defining hypo-methylated regions of stem cell-specific promoters in human ips cells der...
6454004 - Bacteriophage phi x174-specific mrna synthesis in cells deficient in termination factor...
3587504 - In vitro distribution of porphyrin metabolites from 10(-3) m delta-aminolevulinic acid ...
16101144 - Sensitisation of ehrlich ascitic tumour cells to methotrexate by inhibiting glutaminase.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-4
Journal Detail:
Title:  Cell biochemistry and function     Volume:  -     ISSN:  1099-0844     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8305874     Medline TA:  Cell Biochem Funct     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 John Wiley & Sons, Ltd.
Laboratory of Cardiovascular - Department of Anatomy, Cellular Biology and Physiology, State University of Campinas (UNICAMP), Biology Institute, 255 Monteiro Lobato, Campinas, SP 13083-970; Brasil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its exp...
Next Document:  HSP70 expression: does it a novel fatigue signalling factor from immune system to the brain?